NWS
79
15
CB
46
-2
AMAT
60
5
AXP
71
-2
MSFT
60
5
DLTR
46
2
SE
57
5
GWW
48
4
C
44
-2
NKE
42
2
QRVO
31
2
EMC
89
15
EIX
58
2
TJX
64
2
KMX
49
2
APH
73
2
WEC
48
2
EXPD
45
5
ZBH
54
3
TDC
70
2
NWS
79
15
CB
46
-2
AMAT
60
5
AXP
71
-2
MSFT
60
5
DLTR
46
2
SE
57
5
GWW
48
4
C
44
-2
NKE
42
2
QRVO
31
2
EMC
89
15
EIX
58
2
TJX
64
2
KMX
49
2
APH
73
2
WEC
48
2
EXPD
45
5
ZBH
54
3
TDC
70
2
Financhill
Back

Verizon Communications Vs. Akero Therapeutics Industry Stock Comparison

Sell
25

VZ
Verizon Communications

Last Price:
38.88
Seasonality Move:
1.29%
Sell
40

AKRO
Akero Therapeutics

Last Price:
19.64
Seasonality Move:
6.97%
Sell
25
Verizon Communications (VZ) is a Sell

Is Verizon Communications a Buy, Sell or Hold?

  • The current Verizon Communications [VZ] share price is $38.89. The Score for VZ is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • VZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $19.66. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VZ Stock Price Chart

What is Verizon Communications's stock price today?

  • The Verizon Communications share price today is $38.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VZ is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $19.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

VZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 40.21 Sell
Chaikin Money Flow: -4879598 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.12 - 41.58) Sell
Bollinger Bands (100): (38.51 - 41.37) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.19 Sell
Relative Strength Index (14 RSI): 35.02 Sell
Chaikin Money Flow: -513518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.95 - 22.91) Sell
Bollinger Bands (100): (20.21 - 26.05) Sell

VZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.37 Sell
20-day SMA: 39.83 Sell
50-day SMA: 40.3 Sell
200-day SMA: 37.04 Buy
8-day EMA: 39.32 Sell
20-day EMA: 39.79 Sell
50-day EMA: 40.07 Sell
200-day EMA: 38.61 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.73 Sell
20-day SMA: 20.95 Sell
50-day SMA: 24.31 Sell
200-day SMA: 28.19 Sell
8-day EMA: 19.96 Sell
20-day EMA: 20.99 Sell
50-day EMA: 22.48 Sell
200-day EMA: 27.07 Sell

Verizon Communications Earnings Growth & VZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.11 per share, and an increase next year of $0.12 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.

Verizon Communications Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):